Abatacept (Enresu) detailed instructions and correct medication instructions

Abatacept (trade name Orencia) is a recombinant fusion protein mainly used for the treatment of autoimmune diseases, especially in rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA) and active psoriatic arthritis (PsA). Its mechanism of action is mainly by inhibiting TT cell activation, thereby reducing inflammatory response and joint damage. Specifically, abatacept binds to CD80/CD86 on the surface of antigen-presenting cells, blocks the binding to CD28 on the surface of T cells, inhibits the co-stimulatory signal of T cells, and thereby downregulates the immune response. This targeting mechanism allows abatacept to reduce the release of inflammatory mediators while having a relatively limited impact on overall immune function, making it well tolerated.

The usage and dosage of abatacept are mainly divided into two methods: intravenous injection (IV) and subcutaneous injection (SC). Intravenous injection is usually calculated based on body weight, and the recommended dose for adults is once every four weeks. The first loading dose can be divided into 250mg, 500mg or 750mg according to body weight, followed by intravenous injection at the same dose every four weeks. Subcutaneous injection is more convenient. The fixed dose for adults is 125 mg. It can be injected subcutaneously in the abdomen, thigh or upper arm once a week. For pediatric patients, the dosage needs to be adjusted according to body weight and followed the guidance of professional physicians to ensure efficacy and safety.

In terms of correct medication guidance, a comprehensive assessment should be conducted before using abatacept, including past infection history, vaccination status, liver and kidney function, and immune status. Patients should carefully check the appearance of the drug before injection to ensure there are no particles, discoloration or precipitation. If subcutaneous injection is used, the injection site must be kept clean, use disposable needles, and avoid injecting at the same location repeatedly. After injection, local skin reactions, such as redness, swelling, pain or itching, should be observed. If there are obvious abnormalities, seek medical attention in time. Intravenous injections need to be performed in hospitals or professional institutions, operated by trained medical staff, and monitored for possible adverse reactions during and after the injection.

When using abatacept, attention should be paid to potential adverse reactions and drug interactions. Common adverse reactions include upper respiratory tract infection, headache, nausea, injection site reactions, and mild to moderate fever. A small number of patients may develop serious infections, allergic reactions, or hematological abnormalities. Therefore, routine blood tests, liver and kidney function tests should be performed regularly during treatment, and symptoms of infection, such as fever, cough, or signs of urinary tract infection, should be closely monitored. For patients who are taking other immunosuppressives or biologics, the risks of combined medication should be evaluated to avoid excessive immunosuppression. In addition, live virus vaccines are usually contraindicated during treatment, and necessary vaccinations should be completed before administration.

In long-term management, patients should follow the physician's guidance, adhere to regular medication, and not increase or decrease the dose or stop medication at will to ensure that the disease is effectively controlled. For pregnant women, lactating women, or patients planning pregnancy, the pros and cons should be weighed under the guidance of a professional physician to decide whether to use abatacept. Through scientific management, standardized injections and regular follow-up, abatacept can significantly improve arthritis symptoms, slow down the process of joint damage, and improve patients' quality of life. Overall, abatacept is a safe, effective immunomodulatory drug suitable for long-term maintenance treatment, but its use must strictly follow the instructions and physician guidance, taking into account efficacy, safety and individual differences.

Reference link:https://www.drugs.com